Structure

Physi-Chem Properties

Molecular Weight:  682.17
Volume:  619.15
LogP:  0.298
LogD:  0.006
LogS:  -3.787
# Rotatable Bonds:  9
TPSA:  284.73
# H-Bond Aceptor:  18
# H-Bond Donor:  9
# Rings:  5
# Heavy Atoms:  18

MedChem Properties

QED Drug-Likeness Score:  0.101
Synthetic Accessibility Score:  4.974
Fsp3:  0.467
Lipinski Rule-of-5:  Rejected
Pfizer Rule:  Accepted
GSK Rule:  Rejected
BMS Rule:  0
Golden Triangle Rule:  Rejected
Chelating Alert:  2
PAINS Alert:  1

ADMET Properties (ADMETlab2.0)

ADMET: Absorption

Caco-2 Permeability:  -6.503
MDCK Permeability:  3.930670936824754e-05
Pgp-inhibitor:  0.077
Pgp-substrate:  0.996
Human Intestinal Absorption (HIA):  0.833
20% Bioavailability (F20%):  0.002
30% Bioavailability (F30%):  0.989

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):  0.049
Plasma Protein Binding (PPB):  82.99195098876953%
Volume Distribution (VD):  0.592
Pgp-substrate:  22.654865264892578%

ADMET: Metabolism

CYP1A2-inhibitor:  0.037
CYP1A2-substrate:  0.093
CYP2C19-inhibitor:  0.018
CYP2C19-substrate:  0.052
CYP2C9-inhibitor:  0.012
CYP2C9-substrate:  0.075
CYP2D6-inhibitor:  0.057
CYP2D6-substrate:  0.117
CYP3A4-inhibitor:  0.043
CYP3A4-substrate:  0.008

ADMET: Excretion

Clearance (CL):  1.317
Half-life (T1/2):  0.877

ADMET: Toxicity

hERG Blockers:  0.333
Human Hepatotoxicity (H-HT):  0.169
Drug-inuced Liver Injury (DILI):  0.986
AMES Toxicity:  0.795
Rat Oral Acute Toxicity:  0.028
Maximum Recommended Daily Dose:  0.005
Skin Sensitization:  0.616
Carcinogencity:  0.087
Eye Corrosion:  0.003
Eye Irritation:  0.3
Respiratory Toxicity:  0.022

Download Data

Data Type Select
General Info & Identifiers & Properties  
Structure MOL file  
Source Organisms  
Biological Activities  
Similar NPs/Drugs  

  Natural Product: NPC470446

Natural Product ID:  NPC470446
Common Name*:   6-Methoxyquercetin-3-O-(4-O-Acetyl)-Alpha-L-Rhamnopyranosyl-(1->6)-Beta-D-Glucopyranoside
IUPAC Name:   [(2S,3R,4S,5R,6R)-6-[[(2R,3S,4S,5R,6S)-6-[2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-6-methoxy-4-oxochromen-3-yl]oxy-3,4,5-trihydroxyoxan-2-yl]methoxy]-4,5-dihydroxy-2-methyloxan-3-yl] acetate
Synonyms:  
Standard InCHIKey:  NMYATQQEONGBHA-ASCKONKUSA-N
Standard InCHI:  InChI=1S/C30H34O18/c1-9-25(45-10(2)31)22(39)24(41)29(44-9)43-8-16-18(35)21(38)23(40)30(47-16)48-28-20(37)17-15(7-14(34)27(42-3)19(17)36)46-26(28)11-4-5-12(32)13(33)6-11/h4-7,9,16,18,21-25,29-30,32-36,38-41H,8H2,1-3H3/t9-,16+,18+,21-,22-,23+,24+,25-,29+,30-/m0/s1
SMILES:  CC1C(C(C(C(O1)OCC2C(C(C(C(O2)OC3=C(OC4=C(C3=O)C(=C(C(=C4)O)OC)O)C5=CC(=C(C=C5)O)O)O)O)O)O)O)OC(=O)C
Synthetic Gene Cluster:   n.a.
ChEMBL Identifier:   CHEMBL2037048
PubChem CID:   57409957
Chemical Classification**:  
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0000261] Phenylpropanoids and polyketides
      • [CHEMONTID:0000334] Flavonoids
        • [CHEMONTID:0001111] Flavonoid glycosides
          • [CHEMONTID:0001583] Flavonoid O-glycosides
            • [CHEMONTID:0003531] Flavonoid-3-O-glycosides

*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO33486 paepalanthus geniculatus Species Eriocaulaceae Eukaryota Flowers Santana do Riacho, State Minas Gerais, Brazil n.a. PMID[22506638]

☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  NP Quantity Composition/Concentration

Organism ID NP ID Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  Biological Activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT20529 NON-MOLECULAR NON-PROTEIN TARGET n.a. Activity = 2.16 mM PMID[529334]

☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.

  Chemically structural similarity: I. Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient

●  The left chart: Distribution of similarity level between NPC470446 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).

Similarity Score Similarity Level Natural Product ID
1.0 High Similarity NPC470449
1.0 High Similarity NPC470445
1.0 High Similarity NPC470447
0.994 High Similarity NPC470455
0.994 High Similarity NPC470451
0.988 High Similarity NPC473571
0.988 High Similarity NPC126784
0.988 High Similarity NPC241423
0.988 High Similarity NPC470443
0.988 High Similarity NPC473682
0.988 High Similarity NPC470444
0.988 High Similarity NPC110941
0.982 High Similarity NPC173837
0.9763 High Similarity NPC473072
0.976 High Similarity NPC198324
0.976 High Similarity NPC89127
0.976 High Similarity NPC472385
0.976 High Similarity NPC65563
0.976 High Similarity NPC8573
0.976 High Similarity NPC169733
0.976 High Similarity NPC471669
0.976 High Similarity NPC470949
0.9706 High Similarity NPC148710
0.9704 High Similarity NPC473073
0.9704 High Similarity NPC473071
0.9701 High Similarity NPC477848
0.9701 High Similarity NPC19108
0.9701 High Similarity NPC49344
0.9701 High Similarity NPC220173
0.9701 High Similarity NPC237435
0.9701 High Similarity NPC294815
0.9701 High Similarity NPC43211
0.9701 High Similarity NPC473327
0.9701 High Similarity NPC264735
0.9701 High Similarity NPC135277
0.9701 High Similarity NPC16194
0.9701 High Similarity NPC101191
0.9701 High Similarity NPC476472
0.9701 High Similarity NPC210094
0.9701 High Similarity NPC253685
0.9701 High Similarity NPC115760
0.9647 High Similarity NPC36138
0.9643 High Similarity NPC473862
0.9643 High Similarity NPC211532
0.9643 High Similarity NPC472380
0.9643 High Similarity NPC472382
0.9643 High Similarity NPC268533
0.9643 High Similarity NPC472384
0.9643 High Similarity NPC233994
0.9641 High Similarity NPC21666
0.9641 High Similarity NPC45522
0.9641 High Similarity NPC4390
0.9641 High Similarity NPC24043
0.9641 High Similarity NPC101026
0.9641 High Similarity NPC169977
0.9641 High Similarity NPC42773
0.9641 High Similarity NPC204693
0.9591 High Similarity NPC470717
0.9591 High Similarity NPC21359
0.9591 High Similarity NPC470416
0.9591 High Similarity NPC470713
0.9591 High Similarity NPC460984
0.9591 High Similarity NPC25946
0.9591 High Similarity NPC470720
0.9586 High Similarity NPC89052
0.9586 High Similarity NPC251417
0.9581 High Similarity NPC60735
0.9581 High Similarity NPC471748
0.9581 High Similarity NPC176740
0.9581 High Similarity NPC476405
0.9581 High Similarity NPC134532
0.9581 High Similarity NPC33054
0.9581 High Similarity NPC153755
0.9581 High Similarity NPC117260
0.9581 High Similarity NPC254540
0.9581 High Similarity NPC155877
0.9581 High Similarity NPC211594
0.9581 High Similarity NPC172807
0.9581 High Similarity NPC471725
0.9581 High Similarity NPC3583
0.9581 High Similarity NPC175107
0.9581 High Similarity NPC26230
0.9581 High Similarity NPC259152
0.9581 High Similarity NPC190003
0.9581 High Similarity NPC203259
0.9535 High Similarity NPC295625
0.9535 High Similarity NPC470719
0.9535 High Similarity NPC473554
0.9532 High Similarity NPC470718
0.9532 High Similarity NPC156785
0.9532 High Similarity NPC241781
0.9532 High Similarity NPC107987
0.9532 High Similarity NPC162394
0.9529 High Similarity NPC192539
0.9527 High Similarity NPC202908
0.9527 High Similarity NPC14187
0.9527 High Similarity NPC219043
0.9527 High Similarity NPC292019
0.9527 High Similarity NPC122467
0.9527 High Similarity NPC48984
0.9521 High Similarity NPC116864
0.9521 High Similarity NPC285197
0.9521 High Similarity NPC136042
0.9521 High Similarity NPC95866
0.9521 High Similarity NPC255157
0.9521 High Similarity NPC235260
0.9521 High Similarity NPC67105
0.9521 High Similarity NPC155763
0.9521 High Similarity NPC245014
0.9521 High Similarity NPC84265
0.9521 High Similarity NPC254855
0.9521 High Similarity NPC67326
0.9521 High Similarity NPC29958
0.9521 High Similarity NPC244776
0.9521 High Similarity NPC282987
0.9521 High Similarity NPC156869
0.9521 High Similarity NPC259896
0.9521 High Similarity NPC20505
0.9477 High Similarity NPC275977
0.9477 High Similarity NPC249560
0.9477 High Similarity NPC223860
0.9474 High Similarity NPC222674
0.9471 High Similarity NPC258044
0.9471 High Similarity NPC139571
0.9471 High Similarity NPC217520
0.9471 High Similarity NPC113836
0.9471 High Similarity NPC35167
0.9471 High Similarity NPC267680
0.9471 High Similarity NPC196127
0.9471 High Similarity NPC293626
0.9471 High Similarity NPC168584
0.9471 High Similarity NPC253521
0.9471 High Similarity NPC120952
0.9471 High Similarity NPC217387
0.9471 High Similarity NPC37668
0.9467 High Similarity NPC142996
0.9467 High Similarity NPC102028
0.9464 High Similarity NPC472386
0.9461 High Similarity NPC201292
0.9461 High Similarity NPC86008
0.9461 High Similarity NPC209296
0.9461 High Similarity NPC45638
0.9461 High Similarity NPC226294
0.9461 High Similarity NPC186807
0.9461 High Similarity NPC203050
0.9461 High Similarity NPC219904
0.9461 High Similarity NPC58053
0.9461 High Similarity NPC138927
0.9461 High Similarity NPC475942
0.9461 High Similarity NPC105025
0.9461 High Similarity NPC227508
0.9461 High Similarity NPC469931
0.9461 High Similarity NPC195257
0.9461 High Similarity NPC223747
0.9461 High Similarity NPC93337
0.9461 High Similarity NPC120099
0.9461 High Similarity NPC225434
0.9422 High Similarity NPC33083
0.9422 High Similarity NPC474093
0.9422 High Similarity NPC104910
0.9412 High Similarity NPC472991
0.9412 High Similarity NPC144097
0.9412 High Similarity NPC472992
0.9412 High Similarity NPC61904
0.9408 High Similarity NPC239549
0.9408 High Similarity NPC236191
0.9408 High Similarity NPC51774
0.9408 High Similarity NPC163165
0.9405 High Similarity NPC22195
0.9405 High Similarity NPC206123
0.9405 High Similarity NPC183357
0.9405 High Similarity NPC21190
0.9401 High Similarity NPC325555
0.9401 High Similarity NPC84362
0.9401 High Similarity NPC52550
0.9401 High Similarity NPC223424
0.9401 High Similarity NPC317489
0.9401 High Similarity NPC265530
0.9401 High Similarity NPC226304
0.9401 High Similarity NPC45618
0.9401 High Similarity NPC58716
0.9401 High Similarity NPC275454
0.9401 High Similarity NPC127546
0.9401 High Similarity NPC173637
0.9401 High Similarity NPC146792
0.9368 High Similarity NPC97817
0.9368 High Similarity NPC30011
0.9368 High Similarity NPC72554
0.9368 High Similarity NPC475179
0.9357 High Similarity NPC472387
0.9357 High Similarity NPC477895
0.9357 High Similarity NPC476621
0.9357 High Similarity NPC476622
0.9357 High Similarity NPC476619
0.9357 High Similarity NPC476618
0.9357 High Similarity NPC476623
0.9357 High Similarity NPC476620
0.9353 High Similarity NPC34267
0.9353 High Similarity NPC214621
0.9353 High Similarity NPC198199

  Chemically structural similarity: II. Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC470446 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.9701 High Similarity NPD4338 Clinical (unspecified phase)
0.9641 High Similarity NPD7251 Discontinued
0.9583 High Similarity NPD7808 Phase 3
0.9581 High Similarity NPD6797 Phase 2
0.9521 High Similarity NPD7472 Approved
0.9461 High Similarity NPD7054 Approved
0.929 High Similarity NPD7074 Phase 3
0.9006 High Similarity NPD7804 Clinical (unspecified phase)
0.8947 High Similarity NPD3818 Discontinued
0.8941 High Similarity NPD6166 Phase 2
0.8941 High Similarity NPD6168 Clinical (unspecified phase)
0.8941 High Similarity NPD6167 Clinical (unspecified phase)
0.8802 High Similarity NPD3817 Phase 2
0.8743 High Similarity NPD2801 Approved
0.8698 High Similarity NPD4381 Clinical (unspecified phase)
0.858 High Similarity NPD7993 Clinical (unspecified phase)
0.858 High Similarity NPD5402 Approved
0.8571 High Similarity NPD1934 Approved
0.8529 High Similarity NPD3882 Suspended
0.848 Intermediate Similarity NPD7075 Discontinued
0.8421 Intermediate Similarity NPD4868 Clinical (unspecified phase)
0.8415 Intermediate Similarity NPD7879 Clinical (unspecified phase)
0.8412 Intermediate Similarity NPD2393 Clinical (unspecified phase)
0.8323 Intermediate Similarity NPD1512 Approved
0.8304 Intermediate Similarity NPD7096 Clinical (unspecified phase)
0.8246 Intermediate Similarity NPD6801 Discontinued
0.8225 Intermediate Similarity NPD1653 Approved
0.8204 Intermediate Similarity NPD1511 Approved
0.8171 Intermediate Similarity NPD5494 Approved
0.8166 Intermediate Similarity NPD5403 Approved
0.8129 Intermediate Similarity NPD4380 Phase 2
0.8122 Intermediate Similarity NPD6559 Discontinued
0.8101 Intermediate Similarity NPD7228 Approved
0.8095 Intermediate Similarity NPD6799 Approved
0.8056 Intermediate Similarity NPD5844 Phase 1
0.8047 Intermediate Similarity NPD5401 Approved
0.8033 Intermediate Similarity NPD8312 Approved
0.8033 Intermediate Similarity NPD8313 Approved
0.8022 Intermediate Similarity NPD7685 Pre-registration
0.8011 Intermediate Similarity NPD8397 Clinical (unspecified phase)
0.8 Intermediate Similarity NPD3751 Discontinued
0.7989 Intermediate Similarity NPD1465 Phase 2
0.7979 Intermediate Similarity NPD7435 Discontinued
0.7978 Intermediate Similarity NPD3787 Discontinued
0.7946 Intermediate Similarity NPD8055 Clinical (unspecified phase)
0.7944 Intermediate Similarity NPD7473 Discontinued
0.7941 Intermediate Similarity NPD4378 Clinical (unspecified phase)
0.7886 Intermediate Similarity NPD7819 Suspended
0.7877 Intermediate Similarity NPD6232 Discontinued
0.7833 Intermediate Similarity NPD7184 Clinical (unspecified phase)
0.7816 Intermediate Similarity NPD6599 Discontinued
0.7778 Intermediate Similarity NPD8151 Discontinued
0.7771 Intermediate Similarity NPD7411 Suspended
0.7765 Intermediate Similarity NPD6190 Approved
0.7746 Intermediate Similarity NPD6980 Clinical (unspecified phase)
0.774 Intermediate Similarity NPD8443 Clinical (unspecified phase)
0.7739 Intermediate Similarity NPD7874 Approved
0.7739 Intermediate Similarity NPD7875 Clinical (unspecified phase)
0.7738 Intermediate Similarity NPD1552 Clinical (unspecified phase)
0.7738 Intermediate Similarity NPD7266 Discontinued
0.7738 Intermediate Similarity NPD1550 Clinical (unspecified phase)
0.7732 Intermediate Similarity NPD6777 Approved
0.7732 Intermediate Similarity NPD6776 Approved
0.7732 Intermediate Similarity NPD6778 Approved
0.7732 Intermediate Similarity NPD6781 Approved
0.7732 Intermediate Similarity NPD6779 Approved
0.7732 Intermediate Similarity NPD6782 Approved
0.7732 Intermediate Similarity NPD6780 Approved
0.773 Intermediate Similarity NPD7240 Approved
0.7722 Intermediate Similarity NPD1247 Approved
0.7722 Intermediate Similarity NPD7199 Phase 2
0.7722 Intermediate Similarity NPD6959 Discontinued
0.7709 Intermediate Similarity NPD6234 Discontinued
0.7709 Intermediate Similarity NPD919 Approved
0.7704 Intermediate Similarity NPD7698 Approved
0.7704 Intermediate Similarity NPD7696 Phase 3
0.7704 Intermediate Similarity NPD7697 Approved
0.77 Intermediate Similarity NPD7782 Clinical (unspecified phase)
0.77 Intermediate Similarity NPD7783 Phase 2
0.7692 Intermediate Similarity NPD1549 Phase 2
0.7684 Intermediate Similarity NPD8455 Phase 2
0.7638 Intermediate Similarity NPD7701 Phase 2
0.7627 Intermediate Similarity NPD37 Approved
0.7602 Intermediate Similarity NPD1878 Clinical (unspecified phase)
0.7598 Intermediate Similarity NPD4967 Phase 2
0.7598 Intermediate Similarity NPD4966 Approved
0.7598 Intermediate Similarity NPD4965 Approved
0.7596 Intermediate Similarity NPD7852 Clinical (unspecified phase)
0.7576 Intermediate Similarity NPD7871 Phase 2
0.7576 Intermediate Similarity NPD7870 Phase 2
0.7574 Intermediate Similarity NPD2796 Approved
0.7538 Intermediate Similarity NPD7700 Phase 2
0.7538 Intermediate Similarity NPD7699 Phase 2
0.7529 Intermediate Similarity NPD7410 Clinical (unspecified phase)
0.7515 Intermediate Similarity NPD1510 Phase 2
0.7487 Intermediate Similarity NPD8090 Clinical (unspecified phase)
0.7487 Intermediate Similarity NPD8320 Phase 1
0.7487 Intermediate Similarity NPD8319 Approved
0.7485 Intermediate Similarity NPD970 Clinical (unspecified phase)
0.7474 Intermediate Similarity NPD6535 Approved
0.7474 Intermediate Similarity NPD6534 Approved
0.7471 Intermediate Similarity NPD6143 Clinical (unspecified phase)
0.7446 Intermediate Similarity NPD3926 Phase 2
0.744 Intermediate Similarity NPD1933 Approved
0.744 Intermediate Similarity NPD230 Phase 1
0.7438 Intermediate Similarity NPD7801 Approved
0.7435 Intermediate Similarity NPD8434 Phase 2
0.7435 Intermediate Similarity NPD8150 Discontinued
0.7413 Intermediate Similarity NPD7584 Approved
0.7403 Intermediate Similarity NPD7768 Phase 2
0.7399 Intermediate Similarity NPD3750 Approved
0.7387 Intermediate Similarity NPD6823 Phase 2
0.7381 Intermediate Similarity NPD1612 Clinical (unspecified phase)
0.7381 Intermediate Similarity NPD1613 Approved
0.7368 Intermediate Similarity NPD2935 Discontinued
0.7368 Intermediate Similarity NPD8155 Clinical (unspecified phase)
0.7365 Intermediate Similarity NPD6859 Clinical (unspecified phase)
0.7363 Intermediate Similarity NPD3749 Approved
0.7337 Intermediate Similarity NPD447 Suspended
0.7323 Intermediate Similarity NPD7237 Clinical (unspecified phase)
0.7299 Intermediate Similarity NPD4628 Phase 3
0.7278 Intermediate Similarity NPD943 Approved
0.7278 Intermediate Similarity NPD1240 Approved
0.7267 Intermediate Similarity NPD1551 Phase 2
0.7264 Intermediate Similarity NPD7680 Approved
0.7232 Intermediate Similarity NPD2532 Approved
0.7232 Intermediate Similarity NPD2534 Approved
0.7232 Intermediate Similarity NPD2533 Approved
0.7219 Intermediate Similarity NPD6233 Phase 2
0.7219 Intermediate Similarity NPD7784 Clinical (unspecified phase)
0.7217 Intermediate Similarity NPD5619 Clinical (unspecified phase)
0.7206 Intermediate Similarity NPD7585 Approved
0.7202 Intermediate Similarity NPD3027 Phase 3
0.7193 Intermediate Similarity NPD1607 Approved
0.7167 Intermediate Similarity NPD7458 Discontinued
0.7157 Intermediate Similarity NPD7583 Approved
0.7151 Intermediate Similarity NPD920 Approved
0.7143 Intermediate Similarity NPD6844 Discontinued
0.7143 Intermediate Similarity NPD7421 Clinical (unspecified phase)
0.7143 Intermediate Similarity NPD1529 Clinical (unspecified phase)
0.712 Intermediate Similarity NPD5953 Discontinued
0.7114 Intermediate Similarity NPD7501 Clinical (unspecified phase)
0.711 Intermediate Similarity NPD651 Clinical (unspecified phase)
0.711 Intermediate Similarity NPD3748 Approved
0.7105 Intermediate Similarity NPD7286 Phase 2
0.7083 Intermediate Similarity NPD1530 Clinical (unspecified phase)
0.7072 Intermediate Similarity NPD3226 Approved
0.7071 Intermediate Similarity NPD6212 Phase 3
0.7071 Intermediate Similarity NPD6214 Clinical (unspecified phase)
0.7071 Intermediate Similarity NPD6213 Phase 3
0.7065 Intermediate Similarity NPD5353 Approved
0.7059 Intermediate Similarity NPD6798 Discontinued
0.7041 Intermediate Similarity NPD6832 Phase 2
0.7039 Intermediate Similarity NPD7004 Clinical (unspecified phase)
0.7039 Intermediate Similarity NPD642 Clinical (unspecified phase)
0.7035 Intermediate Similarity NPD6355 Discontinued
0.7011 Intermediate Similarity NPD7033 Discontinued
0.6959 Remote Similarity NPD2313 Discontinued
0.6959 Remote Similarity NPD7549 Discontinued
0.6949 Remote Similarity NPD6674 Discontinued
0.6949 Remote Similarity NPD2800 Approved
0.6949 Remote Similarity NPD1243 Approved
0.6949 Remote Similarity NPD1652 Phase 2
0.6942 Remote Similarity NPD7211 Clinical (unspecified phase)
0.6932 Remote Similarity NPD2346 Discontinued
0.6927 Remote Similarity NPD643 Clinical (unspecified phase)
0.6914 Remote Similarity NPD2799 Discontinued
0.691 Remote Similarity NPD6398 Clinical (unspecified phase)
0.6902 Remote Similarity NPD6385 Approved
0.6902 Remote Similarity NPD7615 Clinical (unspecified phase)
0.6902 Remote Similarity NPD6386 Approved
0.6895 Remote Similarity NPD5242 Approved
0.6888 Remote Similarity NPD7090 Clinical (unspecified phase)
0.6882 Remote Similarity NPD9494 Approved
0.6878 Remote Similarity NPD8127 Discontinued
0.6878 Remote Similarity NPD5006 Approved
0.6878 Remote Similarity NPD5005 Approved
0.6875 Remote Similarity NPD6100 Approved
0.6875 Remote Similarity NPD6099 Approved
0.6872 Remote Similarity NPD4419 Clinical (unspecified phase)
0.6866 Remote Similarity NPD4360 Phase 2
0.6866 Remote Similarity NPD4363 Phase 3
0.6864 Remote Similarity NPD1203 Approved
0.6857 Remote Similarity NPD7097 Phase 1
0.6842 Remote Similarity NPD5710 Approved
0.6842 Remote Similarity NPD5711 Approved
0.684 Remote Similarity NPD7930 Approved
0.6839 Remote Similarity NPD5124 Phase 1
0.6839 Remote Similarity NPD1899 Clinical (unspecified phase)
0.6839 Remote Similarity NPD5123 Clinical (unspecified phase)
0.6826 Remote Similarity NPD1091 Approved
0.6806 Remote Similarity NPD7907 Approved
0.6804 Remote Similarity NPD8058 Clinical (unspecified phase)
0.6804 Remote Similarity NPD8059 Phase 3
0.68 Remote Similarity NPD6651 Approved
0.6796 Remote Similarity NPD7390 Discontinued
0.6793 Remote Similarity NPD5808 Clinical (unspecified phase)
0.6787 Remote Similarity NPD8067 Phase 3
0.6786 Remote Similarity NPD9269 Phase 2
0.6782 Remote Similarity NPD4060 Phase 1

  Bioactivity similarity: Similar Natural Products in NPASS

Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.

Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data